Global Genome Editing Market Is Expected To Reach Around USD 13.23 Billion By 2032

Zion Market Research has published a new report titled “Genome Editing Market by Technology (CRISPR, TALEN, ZFN, Antisense, and Others), by Application (Cell Line Engineering, Genetic Engineering, and Others), and by End-User (Pharmaceutical & Biotechnological Companies, Academic and Research Institutes, and Contract Research Organizations): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032”. According to the report, the global genome editing market was approximately USD 6.21 billion in 2023 and is expected to generate around USD 13.23 billion by 2032, at a CAGR of around 8.76% between 2024 and 2032.

Genome editing is used precisely to modify the DNA present within a particular cell. Genome editing mainly involves cutting the specific sequence of DNA with the help of enzymes, which are also called engineered nucleases. This technique can also be used to remove, alter, or add a particular DNA segment in a genome. The growing number of research activities for the treatment of chronic diseases using genome editing technology is fueling the global genome editing market. However, the lack of skilled professionals, high equipment cost, and negative public opinion about genetic research may hinder the global genome editing market.

Browse the full “Genome Editing Market by Technology (CRISPR, TALEN, ZFN, Antisense, and Others), by Application (Cell Line Engineering, Genetic Engineering, and Others), and by End-User (Pharmaceutical & Biotechnological Companies, Academic and Research Institutes, and Contract Research Organizations): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032” Report at https://www.zionmarketresearch.com/report/genome-editing-genome-engineering-market

The global genome editing market is divided based on technology, application, and end-user. Based on technology, the genome editing market includes ZFN, antisense, CRISPR, TALEN, and others. ZFN is anticipated to show notable growth over the forecast time period, owing to its various benefits. CRISPR dominated the genome editing market in 2018, due to the increase in initiatives and funding by the government for the development of drugs and vaccines that use CRISPR technology.

By application, the market is fragmented into genetic engineering, cell line engineering, and others. Cell line engineering is expected to witness the highest growth rate in the future, owing to the increasing research activities of stem cells for the treatment of various diseases, growing awareness about stem cell therapy benefits, and rising government funding for stem cell research.

The end-user segment comprises contract research organizations, pharmaceutical and biotechnological companies, and academic and research institutes. Academic and research institutes are anticipated to register good growth, owing to the growing research activities related to genetic engineering and stem cell therapies and increasing government funding for these research projects. Pharmaceutical and biotechnological companies dominated the market in 2018, due to the growing establishment of biotech and pharma companies in developing countries.

North America is projected to dominate the global genome editing market in the years ahead, owing to the early introduction of highly developed equipment and techniques, availability of a highly skilled workforce, and the presence of major companies. The Asia Pacific region is anticipated to show the highest CAGR in the upcoming years, due to the rising government investments for stem cell research, growing establishments of pharmaceutical companies in India and China, and the presence of a large patient pool suffering from chronic diseases.

Some major players of the global genome editing market are Thermo Fisher Scientific, Transposagen Biopharmaceuticals, Horizon Discovery, Editas Medicine, GenScript, Integrated DNA Technologies, Sangamo BioSciences, Lonza Group, OriGene Technologies, Merck, New England Biolabs, and CRISPR Therapeutics.

This report segments the global genome editing market into:

Global Genome Editing Market: Technology Analysis

• CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
• TALEN (Transcriptor-Activator-Like Effector Nuclease)
• ZFN (Zinc Finger Nucleases)
• Antisense
• Others

Global Genome Editing Market: Application Analysis

• Cell Line Engineering
• Genetic Engineering
• Others

Global Genome Editing Market: End-User Analysis

• Pharmaceutical and Biotechnological Companies
• Academic and Research Institutes
• Contract Research Organizations

Global Genome Editing Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com